Full text loading...
- ISSN: 1871-5303
- E-ISSN: 2212-3873
-
Theranostic Nanoparticles for Pancreatic Cancer Treatment
- Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Volume 21, Issue 2, Feb 2021, p. 203 - 214
-
- 01 Feb 2021
Abstract
Pancreatic cancer is one of the low vascular permeable tumors with a high mortality rate. The five-year survival period is ∼5%. The field of drug delivery is at its pace in developing unique drug delivery carriers to treat high mortality rate cancers such as pancreatic cancer. Theranostic nanoparticles are the new novel delivery carriers where the carrier is loaded with both diagnostic and therapeutic agents. The present review discusses various therapeutic and theranostic nanocarriers for pancreatic cancer.
© Bentham Science Publishers